Loading clinical trials...
Loading clinical trials...
Over half of chronic obstructive pulmonary disease (COPD) patients develop pulmonary hypertension. The current therapy focuses only on the basic disease and there are a lot of controversies about the ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
NCT06847061 · Chronic Obstructive Pulmonary Disease (COPD
NCT05746039 · Obesity, Interstitial Lung Disease, and more
NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)
NCT07383896 · Asthma, COPD
NCT07112235 · COPD (Chronic Obstructive Pulmonary Disease), Rhinovirus Infection, and more
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions